Back

Mechanisms of action and synergies of a novel lipid IVA biosynthesis inhibitor

Holden, E. R.; Yasir, M.; Turner, A. K.; Webber, M. A.; Charles, I. G.; Siegwart, E.; Raynham, T.; Mistry, A.; George, J.; Gilmour, M.

2023-09-15 molecular biology
10.1101/2023.09.15.557861 bioRxiv
Show abstract

The development of novel antimicrobials provides additional treatment options for infectious diseases, including antimicrobial resistant infections. There are many hurdles to antimicrobial development and identifying an antimicrobials mechanism of action is a crucial step in progressing candidate molecules through the drug discovery pipeline. We used the genome wide screening method TraDIS-Xpress to identify genes in two model Gram-negative bacteria that affected sensitivity to three analogues of a novel antimicrobial compound (OPT-2U1). TraDIS-Xpress identified that all three analogues targeted the lipid IVA biosynthetic pathway in E. coli and Salmonella Typhimurium. Specifically, we determined that the antimicrobial target was likely to be LpxD, and validated this by finding a 5 log2-fold increase in the MIC of the OPT-2U1 analogues in E. coli when lpxD was overexpressed. Synergies were identified between OPT-2U1 analogues combined with rifampicin or colistin, to varying strengths, in both E. coli and S. Typhimurium. LPS composition was a likely reason for differences between E. coli and S.Typhimurium, as perturbation of LPS synthesis affected synergy between antibiotics and OPT-2U1 analogues. Finally, genes involved in ATP synthesis and membrane signalling functions were also found to affect the synergy between colistin and OPT-2U1 analogues. TraDIS-Xpress has proven a powerful tool to rapidly assay all genes (and notably, essential genes) within a bacterium for roles in dictating antimicrobial sensitivity. This study has confirmed the predicted target pathway of OPT-2U1 and identified synergies which could be investigated for development of novel antimicrobial formulations. Data SummaryNucleotide sequence data supporting the analysis in this study has been deposited in ArrayExpress under the accession number E-MTAB-13250. The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
ACS Infectious Diseases
74 papers in training set
Top 0.1%
29.0%
2
Antibiotics
32 papers in training set
Top 0.1%
9.6%
3
ACS Chemical Biology
150 papers in training set
Top 0.2%
5.1%
4
PLOS ONE
4510 papers in training set
Top 33%
4.5%
5
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 0.6%
3.9%
50% of probability mass above
6
Frontiers in Microbiology
375 papers in training set
Top 3%
3.2%
7
Scientific Reports
3102 papers in training set
Top 43%
2.9%
8
mSystems
361 papers in training set
Top 4%
2.2%
9
eLife
5422 papers in training set
Top 34%
2.2%
10
Journal of Chemical Information and Modeling
207 papers in training set
Top 2%
2.2%
11
Microbiology Spectrum
435 papers in training set
Top 2%
2.2%
12
Nature Communications
4913 papers in training set
Top 46%
2.2%
13
International Journal of Molecular Sciences
453 papers in training set
Top 6%
2.0%
14
mBio
750 papers in training set
Top 7%
1.9%
15
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 3%
1.4%
16
Microorganisms
101 papers in training set
Top 1%
1.4%
17
PLOS Pathogens
721 papers in training set
Top 7%
1.2%
18
Pathogens
53 papers in training set
Top 1%
0.9%
19
BMC Microbiology
35 papers in training set
Top 1%
0.9%
20
The Journal of Infectious Diseases
182 papers in training set
Top 4%
0.8%
21
iScience
1063 papers in training set
Top 28%
0.8%
22
ACS Omega
90 papers in training set
Top 4%
0.8%
23
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 43%
0.8%
24
PLOS Genetics
756 papers in training set
Top 15%
0.8%
25
Frontiers in Molecular Biosciences
100 papers in training set
Top 6%
0.7%
26
Frontiers in Public Health
140 papers in training set
Top 9%
0.7%
27
Genomics
60 papers in training set
Top 3%
0.7%